Beta Bionics, Inc. (BBNX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 27.63M | 32.12M | 27.25M | 23.24M | 17.64M | 20.44M | 16.7M | 12.93M | 8.35M |
| Revenue Growth % | 56.62% | 57.15% | 63.14% | - | 36.39% | 144.79% | - | - | - |
| Cost of Goods Sold | 11.19M | 13.18M | 12.13M | 10.73M | 8.67M | 8.75M | 7.79M | 5.73M | 3.29M |
| COGS % of Revenue | 40.5% | 41.02% | 44.52% | 46.2% | 49.14% | 42.81% | 46.64% | 44.32% | 39.38% |
| Gross Profit | 16.44M | 18.94M | 15.12M | 12.5M | 8.97M | 11.69M | 8.91M | 7.2M | 5.06M |
| Gross Margin % | 59.5% | 58.98% | 55.48% | 53.8% | 50.86% | 57.19% | 53.36% | 55.68% | 60.62% |
| Gross Profit Growth % | 83.22% | 62.07% | 69.61% | - | 24.58% | 130.92% | - | - | - |
| Operating Expenses | 40.71M | 35.07M | 32.16M | 32.38M | 27.61M | 24.73M | 19.89M | 16.65M | 13.43M |
| OpEx % of Revenue | 147.35% | 109.17% | 118.01% | 139.32% | 156.55% | 120.97% | 119.07% | 128.77% | 160.83% |
| Selling, General & Admin | 30.35M | 24.94M | 23.97M | 23.5M | 20.02M | 15.51M | 14.75M | 11.18M | 8.97M |
| SG&A % of Revenue | 109.87% | 77.63% | 87.94% | 101.14% | 113.52% | 75.89% | 88.3% | 86.41% | 107.41% |
| Research & Development | 10.36M | 10.13M | 8.2M | 8.87M | 7.59M | 9.21M | 5.14M | 5.48M | 4.46M |
| R&D % of Revenue | 37.49% | 31.54% | 30.07% | 38.18% | 43.03% | 45.08% | 30.78% | 42.36% | 53.41% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.27M | -16.12M | -17.04M | -19.87M | -18.64M | -13.04M | -10.98M | -9.45M | -8.37M |
| Operating Margin % | -87.86% | -50.2% | -62.54% | -85.52% | -105.69% | -63.78% | -65.71% | -73.09% | -100.2% |
| Operating Income Growth % | -30.2% | -23.68% | -55.26% | - | -97.21% | -55.81% | - | - | - |
| EBITDA | -24.27M | -18.06M | -16.36M | -19.22M | -18.04M | -12.51M | -10.67M | -8.89M | -8.07M |
| EBITDA Margin % | -87.86% | -56.24% | -60.03% | -82.71% | -102.26% | -61.19% | -63.88% | -68.74% | -96.71% |
| EBITDA Growth % | -34.55% | -44.42% | -53.32% | - | -102.9% | -54.9% | - | - | - |
| D&A (Non-Cash Add-back) | 0 | -1.94M | 683K | 653K | 604K | 529K | 306.33K | 563K | 292K |
| EBIT | -24.27M | -13.46M | -14.21M | -16.87M | -18.64M | -18.11M | -10.98M | -9.45M | -8.37M |
| Net Interest Income | 2.38M | 2.66M | 2.83M | 3M | 2.44M | 953K | 822K | 1.14M | 1.25M |
| Interest Income | 2.38M | 2.66M | 2.83M | 3M | 2.44M | 951K | 826K | 1.14M | 1.25M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.38M | 2.66M | 2.83M | 3M | -10.01M | -5.07M | 1.24M | -3M | -10.48M |
| Pretax Income | -21.89M | -13.46M | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M | -12.45M | -18.85M |
| Pretax Margin % | -79.25% | -41.92% | -52.14% | -72.59% | -162.46% | -88.59% | -58.28% | -96.26% | -225.72% |
| Income Tax | 0 | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -0.01% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -21.89M | -13.47M | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M | -12.45M | -18.85M |
| Net Margin % | -79.25% | -41.92% | -52.14% | -72.59% | -162.46% | -88.59% | -58.28% | -96.26% | -225.72% |
| Net Income Growth % | 23.59% | 25.64% | -45.94% | - | -130.19% | 3.93% | - | - | - |
| Net Income (Continuing) | -21.89M | -13.47M | -14.21M | -16.87M | -28.66M | -18.11M | -9.74M | -12.45M | -18.85M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.49 | -0.30 | -0.33 | -0.39 | -0.93 | -0.42 | -1.55 | -0.41 | -3.13 |
| EPS Growth % | 47.31% | 28.57% | 78.71% | - | -126.83% | 86.58% | - | - | - |
| EPS (Basic) | -0.49 | -0.30 | -0.33 | -0.39 | -0.93 | -0.42 | -1.55 | -0.41 | -3.13 |
| Diluted Shares Outstanding | 44.44M | 40.53M | 43.63M | 43.39M | 30.71M | 43.35M | 43.35M | 30.5M | 6.03M |
| Basic Shares Outstanding | 44.44M | 40.53M | 43.63M | 43.39M | 30.71M | 43.35M | 43.35M | 30.5M | 6.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |